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ABSTRACT
Reduced partial pressure of oxygen impairs exercise performance at altitude. Acute
nitrate supplementation, at sea level may reduce oxygen cost during submaximal exercise
in hypoxia. Therefore, we investigated the metabolic response during exercise at altitude
following acute nitrate consumption. Ten well-trained (61.01±7.37 ml/kg/min) males
(age 28±7 yr) completed 3 experimental trials (T1, T2, T3). T1 included baseline
demographics, a maximal aerobic capacity test (VO2max) and five submaximal intensity
cycling determination bouts at an elevation of 1600m. A 4-day dietary washout,
minimizing consumption of nitrate rich foods, preceded T2 and T3. In a randomized,
double-blind, placebo-controlled, crossover fashion, subjects consumed a placebo (PL) or
nitrate rich (NR) beverage 2.5 hours prior to T2 and T3. Exercise at 3500m (T2 and T3)
consisted of a 5-min warm-up (25% ̇ O2max) and four 5-min cycling bouts (40, 50, 60,
70% of ̇ O2max) each separated a 4-min rest period. Cycling RPM and watts for each
submaximal bout were determined during T1. Pre-exercise plasma nitrite was elevated
following NR consumption compared to PL (p<0.05). Oxygen consumption, respiratory
exchange ratio, oxygen saturation, heart rate and rating of perceived exertion were not
different at any submaximal intensity between NR and PL treatments. Blood lactate,
however, was reduced following NR consumption compared to PL at 40 and 60% of
̇ O2max (p<.0.05). Following exercise, compared to rest, catalase and 8-isoprostane
increased at 3500m in both the placebo and nitrate rich groups (p<0.05). There was no
difference between groups (placebo vs nitrate rich) for either of these markers of
oxidative stress. Our findings suggest that acute nitrate supplementation prior to exercise
at 3500m does not reduce oxygen cost or oxidative stress, but may reduce lactate
production at lower intensity workloads.
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Chapter 1 Introduction to Study
Introduction
Initially, nitric oxide (NO) was deemed a potent vasodilator capable of increasing
blood flow via relaxation of vascular endothelium (1). However, NO has also been
implicated in a number of other functions such as improved or increased exercise induced
glucose uptake (2), neurotransmission (3), immune response (4), regulation of
mitochondrial respiration (5–7), and AMPK-mediated enhancement of glycolysis (8,9).
The production of nitric oxide has been classified under two separate pathways: 1) the
oxygen dependent L-arginine-nitric oxide pathway (10,11) and 2) the oxygen
independent nitrate-nitrite-nitric oxide pathway (12–14). The oxygen dependent pathway
occurs as nitric oxide and L-citrulline are synthesized from the oxidation of L-arginine.
The oxygen independent pathway provides an important complement to the L-argininenitric oxide pathway especially under circumstances of hypoxia and/or impaired NOS
availability (12,13,15,16). Moreover, during exercise, the nitrate-nitrite-nitric oxide
pathway has been implicated in reduced oxygen cost and increased mitochondrial
efficiency over a number of submaximal workloads (17–21). Exploitation of this pathway
may provide potential ergogenic effects during endurance based activities.

NO production from Nitrate and Nitrite
Nitrite (NO2-) is both a product of endogenous NO oxidation and nitrate (NO3-)
reduction. Inorganic NO3- from dietary intake forms NO2- after interacting with
facultative anaerobic bacteria in the mouth (22,23). Once swallowed, NO2- is converted
to NO within the acidic environment of the stomach (24). This is contrary to original
conclusions which postulated NO2- and NO3- were endogenously inert end products of
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NO. It is now clear that NO3- and NO2- provide an auxiliary oxygen independent pathway
for NO formation. This may be especially important under conditions of hypoxia (i.e.
exercise) where the oxygen dependant L-arginine route may be limited by the decreased
bioavailability of nitric oxide synthase (NOS), nicotinamide adenine dinucleotide
phosphate (NADHP) flavin adenine dinucleotide (FAD) and other related co-factors (11).
Nitrate is absorbed directly from the gastrointestinal tract with plasma NO3- levels
reaching their peak between 60 minutes (25) and 2.5 hours (26). After either sodium
nitrate or inorganic NO3- ingestion, plasma concentration of NO2- increases (16, 26–28).
Therefore, the initial reduction of NO3- to NO2- occurs in the mouth. As a result, if
antibacterial mouthwash is administered prior to NO3- ingestion conversion of NO3- to
NO2- is attenuated. Antibacterial mouthwash abolishes commensal oral bacteria causing a
decrement in nitrate reductase activity (30).
This oxygen independent pathway allows for NO production even during
conditions of hypoxia, acidosis or other heavy exercise circumstances. Therefore, an
increase in plasma NO3- and NO2- may increase NO production even when NOS and
endothelial NOS (eNOS) expression are limited by hypoxia or related oxidative stress
(31, 32). Therefore, dietary supplementation which elevates NO2- and NO3- plasma
concentrations, increases NO syntheses over a wide range of exercise intensities as NO
may be less impacted by down regulation of the L-arginine pathway during extreme
exercise intensities or hypoxic conditions. Further, the alternative nitrate-nitrite-nitric
oxide pathway may facilitate physical activity at altitude which is predicated by reduced
partial pressure and a concomitant reliance on oxygen independent NO production (33).
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High Altitude and Plasma Nitrite Concentration
The plasma NO2- concentration of individuals residing at high altitude may be
greater than values of those residing at or near sea level. Compared to residents at 206 m,
Tibetans (residing at 4200m) show greater bioactive NO products of plasma and red
blood cell NO3- as well as increased plasma NO2- (34). In addition, alongside greater
forearm blood flow and lower vascular resistance, NO production was increased in
highlanders compared to sea level residents (34). In the previously mentioned study,
dietary intake was monitored and intake of dietary nitrate was “not at a level expected to
significantly increase circulating nitrate or nitrite” (34). As a result of high altitude
acclimatization, residents may experience an increase in plasma biomarkers of NO
production (NO3- and NO2-) as well as elevated cGMP. This may indicate that individuals
acclimatized to high altitude may have increased NO activity (35). Reduction of
circulating NO2- occurs as hypoxia increases (35). This decline in NO2- concentration
may explain the importance of the oxygen independent conversion of plasma NO2- to
NO.
Via allosteric NO2- reduction by hemoglobin, NO2- can also be converted to NO
as evidenced by the formation of iron-nitrosylated hemoglobin. Forearm blood flow
during exercise increased in vivo, following infusion of NO2- regardless of whether a
nitric oxide synthase (NOS) inhibitor was present (36). Such findings highlight the
complementary nature of the nitrate-nitrite-nitric oxide pathway when production of NO
via NOS (i.e. conversion of L-arginine to NO and L-citrulline) is impaired. Interestingly,
the maximal rate of NO conversion from NO2- (via deoxyhemoglobin) occurs when at
50% hemoglobin saturation (12). Shiva and colleagues (37) also reported that compared
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to deoxyhemoglobin, deoxymyoglobin reduces NO2- to NO approximately 36 times
faster.

Exercise Benefits (efficiency and performance)
Nitrate supplementation via nitrate salts (sodium nitrate) or food sources such as
fruits and vegetables (sources of inorganic nitrate) has been shown to increase both
plasma NO3- and NO2- concentration in as little as 2 (27) or 3 (20, 21) days of loading.
While loading protocols vary in duration from 2-6 days, acute supplementation within 23 hours of exercise has also demonstrated marked increases in both plasma NO3- and
NO2- (28, 29, 33, 34). Such protocols generally initiated loading with approximately 4-6
mmol/day of NO3- although amounts as large as 16.8 mmol have been used (40).
The dietary nitrate induced increase in plasma nitrite allows for greater NO
bioavailability via the nitrate-nitrite-nitric oxide pathway. While resting cyclic guanosine
monophosphate (cGMP) is not altered with 3 days of sodium nitrate supplementation (0.1
mmol/kg/day), increased mitochondrial efficiency is present due to reduced proton
leakage across the inner mitochondrial membrane; possibly due to reduced ADP/ATP
translocase (ANT) protein expression (21). Mitochondrial efficiency is increased as the
amount of oxygen consumed per ATP produced (P/O ratio) has been shown to increase
after nitrate supplementation. Therefore, less proton leak occurs in the presence of higher
maximal ATP synthesis rate (21).
In contrast to the thought that mitochondrial P/O ratio impacts oxygen cost after
nitrate supplementation, reduced total ATP cost during muscle contraction has also been
implicated as the cause of reduced oxygen cost (lower ̇ O2 for a given submaximal
workload) during exercise (41). This theory posits that muscle force production requires
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less total ATP as opposed to the converse theory suggesting the mitochondrial P/O ratio
increases. To further support the reduced ATP cost theory, results have shown reduced
PCr degradation in addition to reduced ADP and Pi accumulation. The authors (41)
suggested if oxygen cost was reduced as a result of a change in mitochondrial efficiency,
there would not have been differences between placebo and nitrate supplementation (beet
juice) for the concentration of PCr and ADP accumulation during exercise.
While principle biochemical mechanisms require additional investigation, nitrate
supplementation has been shown to reduce ̇ O2 over a number of submaximal exercise
intensities (17, 19–21, 27–29, 37). Research has found nitrate supplementation improves
performance during cycling-, rowing- and running-based activities (17, 34, 38–40),
although, others have found no performance-based ergogenic effects post-nitrate
supplementation (45–47).

Practical Application
It is possible that oxygen cost is reduced under a number of submaximal
workloads for both recreationally trained and elite athletes alike at sea level (17, 19–21,
27–29, 37). An increase in plasma nitrite, NO2-, occurs in response to nitrate
supplementation via both nitrate salts (NaNO3-) or whole foods high in nitrate content;
such foods include: celery, cress, chervil, lettuce, red beetroot, spinach, and rocket
(rucola) (48). The increased plasma nitrite content is thought to play a role in NO
production; increased NO production has been associated with increased mitochondrial
efficiency and/or reduced ATP cost during submaximal activity. As such, the ergogenic
potential of nitrate supplementation has been established (17, 34, 38–40). Results from a
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number of studies, however, provide conflicting evidence with regards to the
performance benefits linked to nitrate supplementation.
Despite a documented reduction in oxygen cost, performance may not be affected
in some individuals. The ergogenic qualities linked to dietary nitrate supplementation
require further investigation for both aerobic and anaerobic activities. Further, a
comparison between normoxic and hypoxic environments may better explain the
contribution of the oxygen independent nitrate-nitrite-nitric oxide pathway during
submaximal exercise.
The possibility exists that after a dietary nitrate loading period, individuals may
actually fall into one of two distinct performance categories: responders and nonresponders (36, 43). Responders were classified as those participants who exhibited an
increase (>30%) in plasma NO2- following NO3- supplementation (47). Individuals who
responded to supplementation, exhibited a 2% reduction in completion time of a 50 mile
time trial (p<0.05). In addition, the chronic effect of nitrate supplementation requires
further investigation. While a majority of studies employ a 2-6 day loading period
(approximately 4-6 mmol/day NO3-), supplementation for 15 days did not demonstrate
any indications of reduced sensitivity to nitrate supplementation (28). Findings illustrated
that oxygen cost was reduced (approximately 4%) during moderate-intensity exercise
(approximately 90% lactate threshold) after the initial ingestion 2.5 hours prior to
exercise and this reduction remained similar throughout the 15 day protocol (measures
taken at 5 and 15 days) (28).
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Importance of Nitrate Availability During Exercise
While consumption of dietary nitrate increases plasma NO2- concentrations, there
is a paucity of literature investigating the change in plasma levels in response to exercise
duration (or changes in plasma NO2- concentration over time while exercising). Previous
work by Larsen et al. (20) demonstrated no change in plasma NO3- with a decline in
plasma NO2- levels in both the placebo and nitrate loaded groups after approximately 35
minutes of exercise with intensity increasing in stages from 45% ̇ O2max to maximal
work. Post-exercise no difference was found for plasma NO2- concentration between
control and NO3- loaded groups. Perhaps, the decline of NO2- over time could be a
potential cause of the non-significant changes found in oxygen cost at higher workloads
(≥85% ̇ O2max).
The current study seeks to examine the NO2- concentration at each submaximal
intensity to further dissect whether a cumulative decline in NO2- could be a cause of the
non-significant findings found by Larsen (20). In addition, plasma NO2- concentration
will be examined alongside reduced oxygen cost to determine whether any correlation
exists between the total NO3- concentration and the total reduction in ̇ O2. Larsen and
colleagues established that there was no difference in oxygen cost at higher exercise
intensity workloads (>85% ̇ O2max). The lack of significance was partially attributed to
the following reasons: 1) “well above lactate threshold in several subjects” 2) ̇ O2 did not
reach a steady-state level 3) After the maximum effort test, the plasma NO2- values where
not different between the NO3- loaded and control group. These conclusions are limited in
that the post-exercise measure of NO2- was taken only after the maximal/exhaustive bout.
Therefore, NO2- changes after each workload were unknown. It is possible that the nonsignificant findings at 85% ̇ O2max were a result of inadequate NO2- concentration, and
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not necessarily the higher intensity of the workload (above lactate threshold). Larsen et
al. (27) illustrated a decline in NO2- after a maximal exercise bout, while plasma NO2then rose during the 30-minute post-exercise recovery. Thus, further research is necessary
to determine the changes in plasma NO2- that occur over time. Change in plasma NO2may be further impacted by exercise intensity; this too merits further investigation.

Conclusions
Supplementation with dietary nitrate does not appear to harm endurance related
performance. However, the impact of dietary NO3- as an ergogenic aid is less supported
given the conflicting literature (17,38,42–47), although, others have found no
performance-based ergogenic effects post-nitrate supplementation. The oxygen cost at
various submaximal workloads are consistently reduced after NO3- supplementation,
although this has not been correlated to time trial performance or changes in power
output. While the ergogenic effect of dietary nitrate supplementation remains
inconclusive, the literature does not establish any reason to believe there would be a
decline in performance using supplementation periods of less than 15 days.
The present study seeks to examine the physical response which dietary nitrate
supplementation incurs during exercise at submaximal intensities while acutely (<3
hours) exposed to high altitude (approximately 3500m). These findings can be utilized by
a number of populations including coaches, athletes, researchers, nutritionists and
dietitians to enhance exercise quality, optimize training, improve health and increase
exercise performance.
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Purpose
The purpose of this study is to investigate the impact that consuming inorganic
dietary nitrate has on both the caloric cost and physical stress experienced by people who
exercise and work at high altitude (HA, 3500m, in this study). The current study seeks to
directly identify what benefit dietary nitrate conveys during submaximal exercise
(increasing in difficulty) under HA conditions as compared to normobaric (approximately
1600m) conditions. We hypothesize that participants who consume this commercially
available dietary supplement (Beet It, James White Drinks Ltd, Ipswich, UK) two to three
hours prior to their test session will undergo less insult to the body. Using the
Hypo/Hyperbaric (“altitude”) chamber belonging to UNM’s Department of Health,
Exercise and Sports Sciences, “insult” will be determined by measuring rating of
perceived exertion, heart rate, blood pressure, number of calories expended (via oxygen
consumption), markers of oxidative stress (cellular damage or other disturbances of the
molecular signaling pathways) and production of blood lactate (before, during and after
exercise). Dietary inorganic nitrate is found in a variety of foods including root
vegetables, green leafy vegetables, and some cured or processed meats (48). The present
study intends to control for dietary nitrate sources while raising blood plasma nitrate and
nitrite (NO3- and NO2-, respectively) via acute supplementation two to three hours before
exercise (26, 28, 34, 35).
In the last 5 years, dietary nitrate research has dramatically increased. Dietary
nitrate has been implicated in reduced oxygen cost (less calories required to sustain
exercise at a particular intensity) and increased mitochondrial efficiency (more energy
production for every oxygen molecule consumed) over a number of submaximal
workloads (17, 19–21). This is important because, at a particular intensity, reducing the
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amount of oxygen consumed by the body may improve performance, especially when
participants are exposed to HA where oxygen transport from the blood to the working
muscle is reduced. Research has found that nitrate supplementation improves
performance during cycling, rowing and running at sea-level (17,38,42–44), although
nitrate supplementation’s impact while exercising at HA is less well known. This study
seeks to fill the knowledge gap surrounding nitrate supplementation and HA exposure.
Previous research has investigated the effect of nitrate consumption on metabolic
cost during exercise; however, limited research is available examining exercise and
nitrate consumption during hypoxic exposure. This study seeks to fill the knowledge gap
surrounding hypoxia and nitrate supplementation during submaximal exercise.
Specific Aim 1

To determine the effect of NO3- supplementation on metabolic oxygen cost at
submaximal exercise intensities (25, 40, 50, 60, 70% of ̇ O2max). It is hypothesized that
participants who consume a commercially available NO3- rich dietary supplement (Beet
It, James White Drinks Ltd, Ipswich, UK) two to three hours prior to their test session
will:
1) Reduce oxygen cost compared to a placebo control
2) Reduce oxidative stress compared to a placebo control
Using a randomized, crossover, double-blind, placebo-controlled design (placebo
vs. NO3- supplementation), we will test these hypotheses.
Rationale: Nitrate is absorbed directly from the gastrointestinal tract with plasma
NO3- levels reaching their peak between 60 minutes (25) and 2.5 hours (26). After either
sodium nitrate or inorganic NO3- ingestion, plasma concentration of NO2- increases (16,
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26–28). Therefore, the initial reduction of NO3- to NO2- occurs in the mouth. As a result,
if antibacterial mouthwash is administered prior to NO3- ingestion conversion of NO3- to
NO2- is attenuated. Antibacterial mouthwash abolishes commensal oral bacteria causing a
decrement in nitrate reductase activity (30).
This oxygen independent pathway allows for NO production even during
conditions of hypoxia, acidosis or other heavy exercise circumstances. Therefore, an
increase in plasma NO3- and NO2- may increase NO production even when NOS and
endothelial NOS (eNOS) expression are limited by hypoxia or related oxidative stress
(31, 32). Therefore, dietary supplementation which elevates NO2- and NO3- plasma
concentrations, increases NO syntheses over a wide range of exercise intensities as NO
may be less impacted by down regulation of the L-arginine pathway during extreme
exercise intensities or hypoxic conditions. Further, the alternative nitrate-nitrite-nitric
oxide pathway may facilitate physical activity at altitude which is predicated by reduced
partial pressure and a concomitant reliance on oxygen independent NO production (33).
Therefore, this nitrate-nitrite-nitric oxide pathway is potentially highlighted during
hypoxia (14).
Specific Aim 2

To examine whether characteristics of oxygen cost vary between participants who
responded to NO3- supplementation compared to participants categorized as “nonresponders” to NO3- supplementation. Non-responders will be identified if they fall into
one or more of the following categories:
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1) Participants exhibit a minimal alteration in plasma NO2- concentration
following NO3- supplementation (increase anticipated) (47).
2) Minimal alteration in plasma NO2- throughout exercise (decrease anticipated)
(26)
3) Non Sig. change in O2 consumption between NR and PL trials (40)
It is hypothesized that participants who fall into a category of “non-responders”
will not exhibit a significant reduction in oxygen cost at any submaximal intensities.
Rationale: Although the bottom line is different, my thought is somewhat based
off of the work of Robert Chapman who “retrospectively divided [participants] into
responders (n=17) and non-responders (n=15) to altitude training on the basis of the
change in sea-level 5,000-m run time determined before and after 28 days of living at
moderate altitude and training at either low or moderate altitude” (49).
In line with this retrospective analysis, Wylie (40) classified participants as
responders and non-responders in a dose-response study. Analysis revealed three nonresponders when 4 mmol dietary NO3- was provided while there were two in the 8 mmol
NO3- treatment and only one in the 16.8 mmol NO3- treatment. Some individuals may,
therefore, require greater acute doses of dietary NO3- to stimulate any positive effects on
exercise capacity.
Therefore, participants will be retrospectively classified into responders and nonresponders. This will allow for comparisons to be made between all participants (nitrate
rich vs. placebo) and separately between responders or non-responders to nitrate
supplementation vs. placebo. It is hypothesized that “responders” to the nitrate rich

13

beverage, when compared to the “non-responders”, may present with significant changes
in oxygen consumption during submaximal exercise.
Specific Aim 3

To determine the relationship between nitrate levels found in the blood and
resulting oxygen cost. To accomplish this aim, blood nitrate levels will be determined
following each submaximal exercise bout. Values from the NO3- loaded trials will be
compared to plasma NO3- values found following the submaximal bouts in the placebo
trials.
It is hypothesized that there is a direct correlation between plasma NO2concentration and oxygen cost. Therefore, if plasma NO2- falls throughout exercise, there
may be an associated change in the oxygen cost difference between the NR and PL
(lower plasma NO2- concentration may result in less change, or reduction, in ̇ O2). It will
also be necessary to determine the relationship between NO3-, NO2- and oxygen cost
above and below lactate threshold. To accomplish this aim, NO2- levels will also be
determined alongside blood lactate values during lower and higher intensity exercise.
Plasma NO2- is expected to significantly increase after NO3- supplementation and during
recovery from exercise. Previous work (26) has determined that participants whose
plasma NO2- concentration declined following high-intensity intermittent exercise exhibited
improvement in performance following dietary NO3- supplementation

Plasma NO2- concentration will be assessed following each submaximal bout.
Rationale: Previous research by Larsen (20) performed a similar protocol to
determine oxygen cost at different exercise intensities and failed to determine a
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significant impact only at higher levels of intensity that were performed at the end of the
protocol (85% ̇ O2max and 100% ̇ O2max). This lack of change may have been due to a
decrease in the available plasma nitrate when these higher intensities were performed.

Scope of the study
The purpose of this study is to investigate the submaximal metabolic response
initiated after acute inorganic nitrate consumption in recreationally trained cyclists during
five minute exercise bouts of increasing intensities while exposed to simulated altitude
(approximately 3500m) via hypobaric hypoxia. A total of 12 male trained cyclists
( ̇ O2max >70% ACSM age predicted normative value) will complete this study. All
subjects will be healthy and free of disease and risk stratified as low risk according to
American College of Sports Medicine criteria.
Participants will be recruited via flyers and word of mouth. For potential inclusion
in the study, participants must be men between 18 and 45 years of age. These ages
correspond to the “low risk” category as identified by the American College of Sports
Medicine (50). Based on the responses to the health history questionnaire, only
participants who are free of cardiovascular, pulmonary, and metabolic diseases will be
invited to continue with the study.
Further, participants entering into the study will be categorized as trained cyclists.
Categorization will be based on 1) prescreening questionnaire responses indicating a
minimum of 150 minutes/week cycling or cardiovascular-based activity for a minimum
of 8 weeks as indicated on a self-reported physical activity history questionnaire and 2)
̇ O2max test results placing the participant above the 70th percentile for his age and sex
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(50). Participants will also attend an informal orientation discussing the study protocol, at
which time interested participants will sign an informed consent document.
After completing IRB-approved consent forms, each participant will schedule
three experimental trials (T1, T2 and T3) to be conducted in the UNM Exercise
Physiology Laboratories. T1 will include baseline demographics, a maximal aerobic
capacity test on an electronically braked cycle ergometer, and a series of submaximal
exercise bouts to establish the intensity (watts) on the bike which corresponds to 25, 40,
50, 60, 70% of ̇ O2max. T2 and T3 will consists of exercise at 3500m using a hypobaric
chamber. Participants will exercise for 5 minutes at each of the predetermined exercise
intensities corresponding to 25, 40, 50, 60, 70% of ̇ O2max with a 4-minute period of
active rest (pedaling against no resistance) between each submaximal exercise bout.
This study will follow a randomized, double-blind, placebo-controlled, crossover
fashion as participants will be assigned to either a placebo (PL) or inorganic nitrate rich
(NR) group. Throughout all supplementation and/or washout periods, to minimize any
confounding effects of their dietary intake, subjects will be asked to minimize their intake
of foods containing high nitrate content. A document outlining nitrate-containing foods
will be provided to each subject to encourage successful compliance.
Participants will be asked to complete a food and activity log 2 days prior to
completing their initial altitude trial (second visit). The participant will be asked to
replicate this food and activity log during the 2 days prior to their second altitude trial
(third visit).

Significance of the Study
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This is one of the first studies to examine the relationship between dietary nitrate
supplementation and reduced oxygen cost during submaximal exercise (25, 40, 50, 60,
70% ̇ O2max) during hypobaric hypoxia (3500m). Previous research found nitrate
supplementation reduced oxygen cost under hypoxic conditions of 11% ambient inspired
oxygen (approximately 5,000 m altitude) while exercising at approximately 45% ̇ O2peak
(51). Other research reports that NO3- supplementation (consuming 3 equal does at 24 h,
12 h and 2.5 h prior to exercise; totaling 9.3 mmol of NO3-) under hypoxic conditions of
14.5% ambient inspired oxygen (approximately 3000 m) restores knee extension (48
watts at 40 pulses/min) time to exhaustion to values similar to those attained under
normoxic conditions (52). Still, further investigation is necessary regarding different
exercise intensities under hypoxic conditions. Findings from the present study examining
nitrate supplementation could be utilized by a number of groups including coaches,
athletes, researchers, nutritionists and dietitians seeking enhanced exercise quality,
optimized training, and improved health during acute exposure (<3 hours) to high altitude
(3500m). Research findings from the present study will also report on topics of clinical
interest including blood pressure and rate-pressure product at rest, during, and after
exercise under hypoxia.
This study will make use of biochemical assays including blood lactate, oxidative
stress, plasma volume, hemoglobin content, hematocrit and NO3- and NO2-. This will
adequately determine the efficacy of dietary nitrate consumption at five different
submaximal exercise intensities while performed under HA conditions.
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Chapter 2 Literature Review
This chapter presents a review article, which has been accepted for publication: Carriker, C.,
Gibson, A., & Mermier, C. (2013). The role of the nitrate-nitrite-nitric oxide pathway during
hypoxia. Journal of Sport and Human Performance, 1(4), 63–78.

The role of the nitrate-nitrite-nitric oxide pathway during hypoxia
Introduction
Human movement and cognition rely on cerebral processing via an intricate neuronal
network. The physiology of cerebral energy metabolism has been recently debated regarding an
astrocyte-neuron lactate shuttle or conventional glucose oxidation as viable substrates (1,2).
Reduced cerebral oxygenation may occur in ischemic stroke patients or during environmental
exposure to high altitude. Cerebral ischemia, under severe cases, may result in not only impaired
cognitive and motor function but neuronal damage or degeneration including either neuronal
apoptosis or necrosis (3). However, if blood flow to regions of the brain is increased, greater
oxygen flux occurs, which may ameliorate the consequences of cerebral ischemia outlined above
(4,5). Recently, dietary nitrate has been shown to reduce oxygen cost during submaximal sea
level exercise (6). Further, the conversion of nitrate to nitrite to nitric oxide has been implicated
as an oxygen independent pathway (7), and as such, may be a potent ergogenic aid during
hypoxic conditions as occurs during high altitude exposure.
Initially, nitric oxide (NO) was deemed a potent vasodilator capable of increasing blood
flow via vascular smooth muscle relaxation and cyclic GMP accumulation (8). However, NO
has also been implicated in a number of other functions such as improved or increased exercise
induced glucose uptake in skeletal muscle (9), neurotransmission (10), immune response (11),
regulation of mitochondrial respiration (12–14), and glycolysis as mediated by AMPK (15,16).
Clinically, NO may ameliorate some of the negative consequences of ischemia/reperfusion injury
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(reduced infarct size and endothelial dysfunction), especially in the heart (17) and brain (5) .
Several studies have noted improved vascular and myocardial function/outcomes when NO was
activated prior to ischemia or reperfusion injury (18–20). Therefore, increased NO
formation/availability during incidence of hypoxia or otherwise impaired blood flow may reduce
neuronal damage, improve cognition, and further improve motor function in individuals
experiencing ischemic conditions.

Brain blood flow during exercise
In addition to pathology surrounding stroke or other vascular compromise, as exercise
intensity nears maximum, the onset of total body exhaustion is initiated. Such a phenomenon is
often commonly recognized as an ‘I need to stop’ feeling. During such maximal exercise, a
slight decline in cardiac output may precede fatigue (21) with a concomitant reduction in brain
blood flow (22) while oxygen extraction may be enhanced in cerebral tissue (23). Under such
maximal exercise conditions, cerebral oxygen demand remains high and in some instances,
oxygen supply may be outpaced by cerebral demand. When this occurs, to avoid damage or
other catastrophic failure, motor unit recruitment is reduced (22). A meta-analysis examining
cardiovascular training status found that untrained participants had reduced oxygen delivery to
the frontal cortex which was determined to be insufficient for demand during high intensity
exercise. As a result, untrained participants incurred insufficient cerebral oxygenation when
compared to trained counterparts (22).
Over a wide range of exercise intensities from rest through high intensity, global cerebral
oxygenation follows a quadratic trend (22). Therefore, cerebral oxygenation increases during
low to moderate intensity exercise and begins to level off when approaching high intensity
exercise. As exercise intensities reach maximum, cerebral oxygenation falls (22). During actual

23

and imagined exercise, an increase in perceived exertion may initiate an increase in regional
cerebral blood flow (within the thalamic region, insular cortex and anterior cingulate cortex or
the medial prefrontal region). Participants who experienced an increase in perceived exertion
during both actual and imagined exercise also incurred an elevated heart rate and blood pressure
(24).
Additionally, when effort/activity is imagined, insular cortex activation increases when a
cardiovascular response occurs simultaneously (25). Homeostatic feedback is afferently relayed
to the dorsal posterior insula, while the appropriate sensation is manufactured within the anterior
insula based on said afferent feedback (26). Given the quadratic trend for cerebral oxygenation
mentioned above, during maximal exercise (when the sensation to cease exercise occurs)
feedback pertaining to cerebral blood flow/oxygenation may initiate protective signaling
mechanisms to down-regulate or stop the exercise/activity prior to catastrophic failure, organ
ischemia or injury.
During maximal intensity exercise, the content of deoxygenated hemoglobin in the brain
rises while cerebral oxygenation in the prefrontal cortex declines (27). The prefrontal cortex
relays information to the motor cortex, and in the presence of decreased prefrontal oxygenation
results in decreased muscle function (28). Under such a relay mechanism, cerebral oxygen
desaturation precedes voluntary exhaustion (29). Ultimately, if brain blood flow were increased,
perception of effort may be reduced and, during maximal exercise, performance may be
improved as motor unit recruitment could remain high for extended durations prior to initiating
volitional cessation.
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Pathways implicated in
nitric oxide production
The production of NO
has been classified under two
distinct pathways (Figure 1).
The first is an oxygen dependent
pathway: L-arginine-nitric oxide
(30,31). This pathway allows
synthesis of nitric oxide and Lcitrulline from the oxidation of
L-arginine by nitric oxide
synthase (NOS) enzymes. Three
different isoforms that generate

Figure 1. Pathways producing nitric oxide via an oxygen
independent (top branch) or oxygen dependent (bottom
branch) mechanism. Dietary nitrate is reduced to nitrite via
facultative anaerobic bacteria while nitrite is further
reduced to nitric oxide in acidic and hypoxic tissues. Larginine also produces NO and L-citrulline via nitric oxide
synthase. VSM: Vascular Smooth Muscle

NO have been previously found, including: neuronal (nNOS), endothelial (eNOS), and inducible
(iNOS) enzymes (10).
The second pathway for NO generation is an oxygen independent pathway: nitratenitrite-nitric oxide (6,32,33). The oxygen independent pathway provides an important
complement to the L-arginine-nitric oxide pathway especially under circumstances of hypoxia
and/or impaired NOS availability (33–37). Moreover, during exercise, the nitrate-nitrite-nitric
oxide pathway has been implicated in reduced oxygen cost and increased mitochondrial
efficiency over a number of sub-maximal workloads (38–42). Exploitation of this pathway may
provide potential ergogenic effects for exercise activities conducted during conditions of hypoxia
such as altitude or pathology (coronary artery disease or congestive heart failure).
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Because oxygen is required for NO synthesis via the L-arginine-nitric oxide pathway,
during incidence of ischemia or hypoxia, drugs which increase NOS activity may be less
efficacious (43–45) and the nitrate-nitrite-nitric oxide pathway may become enhanced during
reduced oxygen availability (33,35). As a result, increased NO production via nitrate/nitrite
availability may provide a key complement during incidence of reduced oxygen tensions.
Therefore, during acute hypoxia (as encountered during unacclimatized high altitude exposure),
it is hypothesized that inorganic nitrate supplementation may reduce incidence of ischemia by
activating NO production via the nitrate-nitrite-nitric oxide pathway. In addition, because
increased plasma nitrite concomitantly reduces oxygen cost during submaximal activity, it is
possible that nitrate supplementation will improve performance despite the reduced oxygen
partial pressure.
Consuming dietary nitrate may result in increased NO formation as nitrate consumption
has previously been shown to increase plasma nitrite (46–48) (an in vivo marker of NO
production (49,50)). Increased NO formation during incidence of hypoxia may negate some of
the negative consequences of the reduced oxygen diffusion gradient between blood and tissues.

NO production from Nitrate and Nitrite
Both the L-arginine-NO pathway (44) and the diet (51,52) contribute to elevated plasma
nitrate (NO3-) and nitrite (NO2-) levels in the body. An increase in plasma NO3- occurs in
response to consumption of either whole foods and/or nitrate salts (NaNO3-) which contain high
levels of NO3-. Natural foods high in NO3- content include the following: celery, cress, chervil,
lettuce, red beetroot, spinach, and rocket (rucola) (51). Meats that have been cured or processed
may contain NO2- as an additive to inhibit bacterial growth. In addition, NO2- is a product of
endogenous NO oxidation and NO3- reduction.
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Inorganic NO3- from dietary intake forms NO2- after interacting with facultative
anaerobic bacteria in the mouth (53,54); this process is also referred to as bacterial nitrate
reductase activity (32). Subsequently, once NO2- swallowed, it is converted to NO within the
acidic stomach (55). This is contrary to original conclusions which postulated NO2- and NO3were endogenously inert end products of NO (56). It is now clear that NO3- and NO2- provide an
auxiliary oxygen independent pathway for NO formation. This may be especially important
under conditions of hypoxia (i.e. intense or near maximal exercise) where the oxygen dependant
L-arginine route may be limited by the decreased bioavailability of NOS, nicotinamide adenine
dinucleotide phosphate (NADHP), flavin adenine dinucleotide (FAD) and other related cofactors (31). In addition, during incidence of hypoxia and ischemia, NO2- has a demonstrated
capacity to reduce tissue injury (35,57–59) and inhibit the generation of reactive oxygen species
(ROS)(60).
Nitrate is absorbed directly from the gastrointestinal tract with plasma NO3- levels
reaching their peak 60 minutes after ingestion (61). After either NaNO3- or inorganic NO3ingestion, plasma NO2- increases (38,62–64). The initial reduction of NO3- to NO2- occurs in the
mouth. Therefore, an antibacterial mouthwash administered prior to NO3- ingestion, attenuates
the downstream conversion of NO3- to NO2- . Antibacterial mouthwash results in the removal of
the commensal oral bacteria and subsequent decrement in nitrate reductase activity (65).
An increase in plasma NO3- and NO2- may increase NO production even when NOS and
eNOS expression are limited by hypoxia or related oxidative stress (66,67). Dietary intake
which elevates NO2- and NO3- plasma concentration, also increases NO synthesis over a wide
range of exercise intensities. During high intensity exercise or instances of hypoxia, NO
production via the NOS catalyst may be compromised due to reduction in the oxygen substrate
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(68). Further, the alternative NO3- to NO2- to NO pathway facilitates activity at altitude which is
predicated with reduced partial pressure and a concomitant reliance on oxygen independent NO
production (69).

High Altitude and Plasma Nitrite concentration
Individuals residing at high altitude may have greater plasma nitrite values than
lowlanders. Tibetans residing at 4200m show greater bioactive NO products of plasma and red
blood cell NO3- as well as increased plasma NO2- compared to residents at 206m (70). This
suggests NO production was increased in highlanders alongside a greater forearm blood flow and
lower vascular resistance compared to residents near sea-level. (70). Dietary intake was
monitored in the previously mentioned study and dietary nitrate was “not at a level expected to
significantly increase circulating nitrate or nitrite” (70). Further, acclimatization to high altitude
results in increased plasma biomarkers of NO production (NO3- and NO2-) as well as elevated
cGMP indicating increased NO activity (71). In fact, enhanced circulatory extraction of NO2occurs as hypoxia increases (increasing altitude) (71) which may explain the importance of the
oxygen independent conversion of plasma NO2- to NO.
NO2- can also be converted to NO via allosteric NO2- reduction by hemoglobin as
evidenced by the formation of iron-nitrosylated hemoglobin. In vivo, infusion of nitrite both
with and without a NOS inhibitor present resulted in increased forearm blood flow during
exercise (72). This points toward the complementary nitrate-nitrite-nitric oxide pathway when
production of NO via NOS is impaired. Further, there was an inverse relationship between ironnitrosylated hemoglobin formation and the oxyhemoglobin saturation (r = –0.7 and P < 0.0001)
(72). The maximal rate of NO conversion from NO2- (via deoxyhemoglobin) occurs when
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hemoglobin is 50% saturated (32). In support of this finding, Shiva and colleagues (73) noted
deoxymyoglobin reduces NO2- to NO approximately 36 times faster than deoxyhemoglobin.

High Altitude and Blood Flow
Sea level residents acclimatizing to high altitude also incur a reduction in blood flow
within microcirculatory blood vessels <50μm in diameter (74). Similar reductions in the blood
flow of microcirculatory small (<25 μm) and medium (26–50 μm) blood vessels was also found
in lowlanders exposed to altitude (>3500m) with an explanation that the cause was perhaps due
to the decreased hematocrit (reduced plasma volume) and the subsequent increase in blood
viscosity (75). The authors add that the reduced blood flow may aid in oxygen delivery as the
time for diffusion is increased at the capillary bed and is therefore a favorable adaptation in
lowlanders acclimatizing to high altitude (75). Participants who supplement with inorganic
nitrate may therefore increase plasma NO2- and subsequently increase the availability of NO in
light of the reduced NO production from L-arginine (32).
As early as 15 minutes of acute altitude exposure (76), systemic vasodilation occurs, in
part, mediated by NO production to ensure adequate oxygenation of tissues. In lowlanders
acclimatized to high altitude (>3500m), both the production and availability of NO is enhanced
(71). Conversely, in the pulmonary circuit, acute altitude exposure results in hypoxic pulmonary
vasoconstriction. In compensation for the hypoxic encounter, alveolar ventilation increases to
offset hypoxemia thereby resulting in respiratory alkalosis (77). The increased pulmonary
vasoconstriction can increase pulmonary capillary pressure which increases capillary leakage
leading to high altitude pulmonary edema (HAPE) (78). Interestingly, pulmonary artery systolic
blood pressure was greatest in individuals who developed HAPE after altitude exposure at
4959m (measurements made over 2 day sojourn). Importantly, those individuals not exhibiting
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HAPE criteria had greater concentrations of nitrate-nitrite, measured via bronchoalveolar lavage
fluid within one day of exposure to 4959m (79). Additionally, the concentration of expired NO
was found to be lowest in individuals susceptible to HAPE during exposure to altitude ( at 12,
24, 36, and 48 hours at 4,559 m); indicative of a dysfunction in pulmonary NO synthesis (80).
Therefore, impaired pulmonary epithelial NO synthesis may result in decreased bioavailability of
NO, and increased pulmonary vasoconstriction may predicate the susceptibility of developing
HAPE.
Given NO’s effect on vascular tone and mitochondrial efficiency, greater NO availability
during altitude exposure has increasing importance as ROS production increases. During
altitude acclimatization, NO production/availability is associated with circulating elevations in
cGMP concentrations (in the absence of changes in natriuretic peptide levels) (71). As reported
by Levett (71), elevations in cGMP at 5,300m were positively correlated with microvascular
blood flow in small (<25 mm diameter) and medium-sized (26–50 mm) vessels (p=0.06 and
p=0.025 respectively; r value not reported), yet the cGMP concentrations were insufficient to
normalize microcirculatory blood velocity at 5,300m (71). During altitude exposure,
pharmacologic intervention such as with tadalafil or sildenafil (both phosphodiesterase-5
inhibitors) inhibit cGMP degradation, thereby increasing cGMP and subsequently preventing the
onset of HAPE (81,82).

Critique
It is hypothesized that during exposure to high altitude, maximal exercise intensity, or
cardiovascular pathology such as associated with stroke, inorganic nitrate supplementation may
reduce incidence of ischemia and improve performance by activating NO production via the
nitrate-nitrite-nitric oxide pathway thereby reducing oxygen cost. The NO production via the
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nitrate-nitrite-NO pathway acts complementary to the L-arginine pathway and may, therefore,
increase NO bioavailability. In addition, nitrate supplementation has previously been shown to
increase mitochondrial efficiency in humans at sea level; however, the benefits at altitude are
less well known.
Increased plasma NO2- concentration occurs both during altitude acclimatization
(>3500m) (71) and during short term (3 day) dietary nitrate supplementation (62). During
exercise in conditions of reduced oxygen partial pressures, increased ROS may result. NO3supplementation increases NO2-, and NO2- has been reported to have cytoprotective capabilities
(i.e. improved mitochondrial oxidative phosphorylation) and to reduce mitochondrial ROS
generation (60). NO2- has been previously established as a reservoir for NO (72) during hypoxia
as NO2- is converted to NO (45).
While a number of physiological adaptations (increased oxygen carrying capacity,
mitochondrial density, ventilatory response etc.) occur in response to altitude acclimatization,
these particular changes occurring in response to NO3- supplementation have not been
researched. Altitude acclimatization induces a number of hematological and non-hematological
changes to improve performance/tolerance during hypoxia. However, the same physical changes
have not been reported during short term NO3- supplementation (<15 days). Therefore,
performance benefits similar to those resulting from altitude acclimatization may not be as likely
despite the increased NO2- and NO bioavailability.
The limited research on dietary NO3- and its influence on cGMP is equivocal. NO3supplementation has been shown to increase cGMP (83,84), but there is also evidence that
suggests dietary NO3- has no influence on plasma levels of cGMP (42,62). Research supporting
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NO3- supplementation and resultant increases in cGMP at altitude is currently unavailable and is
therefore, an area open for future research. Examination of soluble guanylyl cyclase activation
during hypoxia could provide an explanation for the benefit of increased bioactivation of NO via
NO3- supplementation. Mice lacking NO-sensitive guanylyl cyclase exhibited increased
hypertension at rest due to the inability to appropriately vasodilate (85). Therefore, regardless if
NO production is normal, when guanalyl cyclase loses sensitivity to NO or is unable to
bind/interact with NO, vascular tone impairments may result in reduced blood flow/oxygen flux
to working muscles. Such a condition may be a primary component of reduced performance
during exercise at altitude.
It is possible that an overabundance of NO via nitrate supplementation (elevated plasma
nitrite) could induce receptor desensitization or hypotension, a negative consequence. While
NO3- supplementation has been shown to reduce blood pressure (83), these effects appear to be
therapeutic in both healthy patients (i.e. reducing blood pressure but not reported to induce
problematic hypotension)(63,86) and patients with peripheral artery disease (64). In fact, the
consumption of natural sources of dietary nitrate, including certain fruits and vegetables (51), has
been generally associated with decreased blood pressure, reduced oxygen cost during
submaximal exercise, and increased exercise tolerance (87).
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Chapter 3 Research Manuscript
This chapter presents a research manuscript, entitled “Effect of acute dietary nitrate consumption on
submaximal oxygen consumption at altitude". This manuscript will be submitted to the International
Journal of Sport Nutrition and Exercise Metabolism.

Effect of acute dietary nitrate consumption on submaximal oxygen
consumption at altitude.
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Introduction
Dietary inorganic nitrate is found in a variety of foods including root vegetables, green
leafy vegetables, and some cured/processed meats (Hord, Tang, & Bryan, 2009). Nitrate
supplementation via nitrate salts (sodium nitrate) and food sources have both been shown to
increase plasma nitrate (NO3-) and plasma nitrite (NO2-) concentrations in as little as two
(Larsen, Weitzberg, Lundberg, & Ekblom, 2010) or three (Larsen, Weitzberg, Lundberg, &
Ekblom, 2007) days of supplementation or consumption. While nitrate loading protocols vary in
duration, i.e. two to six days, acute supplementation within two to three hours of exercise has
been shown to increase both plasma NO3- and NO2- (Bescós et al., 2011; Lansley, Winyard,
Bailey, et al., 2011; Vanhatalo et al., 2010).
Plasma NO2- is recognized as an in vivo biomarker of nitric oxide (NO) production
(Kleinbongard et al., 2003; Lauer et al., 2001). The nitrate-nitrite-nitric oxide pathway may
provide potential ergogenic effects during endurance activities during hypoxia (Carriker, Gibson,
& Mermier, 2013). Little research has explored the ergogenic potential of dietary nitrate at
altitude; however, nitrate supplementation appears to reduce ̇ O2 during submaximal exercise
near sea level (Bailey et al., 2009; Lansley, Winyard, Bailey, et al., 2011; Lansley, Winyard,
Fulford, et al., 2011; Larsen et al., 2007, 2010, 2011). Nonetheless, these sea level investigations
may only represent a recreationally trained population ( ̇ O2max 40-60 ml/kg/min) (Cermak,
Gibala, & van Loon, 2012; Lansley, Winyard, Bailey, et al., 2011; Lansley, Winyard, Fulford, et
al., 2011; Larsen et al., 2007, 2011). Studies using subjects with mean ̇ O2max values >60
ml/kg/min demonstrated no change in submaximal oxygen cost and no improvement in
performance following nitrate supplementation vs placebo (Bescós et al., 2012; Cermak, Res, et
al., 2012; Peacock et al., 2012; Wilkerson et al., 2012). Interestingly, unpublished data from our
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lab (1600m) showed that untrained subjects (mean ̇ O2max 43.79 ml/kg/min) consistently
consumed less oxygen during exercise at workloads <60% ̇ O2max following a 4-day nitrate
supplementation loading protocol.
During altitude acclimatization at 3500m, plasma NO3- and NO2- have been shown to be
elevated in as little as 2-5 days (Janocha et al., 2011; Levett et al., 2011). Moreover, the plasma
NO2- concentration of individuals residing at high altitude may be greater than values of those
residing at or near sea level after controlling for dietary NO3- (Erzurum et al., 2007). This may
lead to enhanced metabolic signaling such as an increase in cyclic guanosine monophosphate,
potentially increasing NO activity (Levett et al., 2011). When exposed to various elevations,
ranging from sea level to 5300m, for 2 to 5 days, participants incurred the greatest increases in
plasma NO3- and NO2- content at ~3500m (Janocha et al., 2011; Levett et al., 2011). Participants
exposed to elevations from 4250m to 5300m had less NO2- concentration than when exposed
3500m, likely as a result of the reduction of circulating NO2- to NO in response to the reduced
partial pressure of oxygen (Janocha et al., 2011; Levett et al., 2011). This decline in NO2concentration may explain the importance of the oxygen independent conversion of plasma NO2to NO as the body encounters a hypoxic environment.
The purpose of this study was to examine the effect of acute dietary nitrate
supplementation on submaximal oxygen cost at 3500m for well-trained cyclists exercising at 40,
50, 60 and 70% of ̇ O2max. We predict that supplementation with dietary nitrate would accelerate
the acclimatization process by raising plasma nitrite prior to altitude exposure at 3500m. We
further predict that the increased levels of plasma nitrite would reduce oxygen consumption and
improve oxygen saturation (SaO2) while exercising under high altitude conditions.
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Methods
Subjects

Ten healthy trained male cyclists (28 ± 7 years; ̇ O2max 61.01 ± 7.37 ml/kg/min) residing
at ~1600m for the previous 6 months volunteered for the study. All subjects provided written
consent for this institutional review board approved study. Subjects were excluded if they
indicated any known cardiovascular, pulmonary or metabolic disease on a health history
questionnaire or incurred extended travel resulting in a change of altitude greater than 400m.

Exercise Tests

All tests were carried out on an electronically braked cycle ergometer (Velotron,
RacerMate, Seattle, WA, USA) with a racing saddle and pedal system similar to those used
during training. The computer-controlled workload allowed subjects to self-select a comfortable
cadence between 70-90 rpm. Preferred cadence and cycle ergometer configuration (seat height,
handle bar height and distance to seat, and pedal preference), were recorded during trial 1 (T1)
and replicated during trial 2 (T2) and trial 3 (T3) to minimize alteration in the muscle recruitment
patterns.
Following T1, subjects were randomized to either the NR or PL intervention following a
4-day nitrate washout (Figure 1a). Subjects were instructed to consume the NR or PL beverage
2.5 hours prior to beginning exercise during T2 and T3. Throughout the 24 hours preceding T2,
subjects were asked to record their dietary intake. Subjects were then instructed to replicate this
diet during the 24 hours prior to T3.
To minimize diurnal variation, subject testing times and days were kept consistent
between trials. Subjects were asked to avoid strenuous exercise, alcohol, chewing gum, and
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mouthwash 24 hours prior to each trial as well as caffeine 12 hours before each trial (items
which may alter NO2- availability) (Govoni, Jansson, Weitzberg, & Lundberg, 2008).
Experimental Protocol

Trial 1: Maximal oxygen consumption test and pre-test determination of submaximal intensities
T1 exercise was completed in a normobaric (1600m) and thermoneutral environment
(~18-21 °C) (Figure 1b). All subjects completed a standardized cycling test to exhaustion which
began with 3 minutes of unloaded cycling followed by a 30 watt/min ramp protocol. Breath-bybreath metabolic gases were continuously collected (True One, ParvoMedics, Sandy, Utah,
USA) and averaged over 11-breath sequences. The ̇ O2max was recorded as the highest value
collected over the 30 seconds prior to the subject’s volitional exhaustion. Following the maximal
exertion test, subjects completed a brief active cool down (~3-5 minutes) and then rested for a
minimum of 15 minutes until the post-exercise heart rate (HR) recovered to within 10 beats of
the resting (baseline) value. During this recovery period, subjects were permitted to sit or
ambulate at their leisure. Subjects then completed five submaximal intensity cycling bouts. This
served to further familiarize the subject with the electronically braked bike and also establish the
resistance and cadence for each T2 and T3 bout (25, 40, 50, 60, and 70% of ̇ O2max).
Trial 2 and 3: Submaximal exercise at altitude
The T2 and T3 exercise sessions were conducted at 3500m via hypobaric hypoxia (Figure
1c). Each submaximal bout was performed for 5 minutes with a 4-minute period of rest
separating the subsequent intensity. The resistance and cadence for T2 and T3 (corresponding to
25, 40, 50, 60, and 70% of ̇ O2max workloads) were determined during T1.
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̇ O2 was assessed over the final 30 seconds of each submaximal exercise bout (True One,
ParvoMedics, Sandy, Utah, USA). HR (short range radiotelemetry via Polar Electro T31, New
York, USA), pulse oximetry (SaO2; Go2 Achieve, Nonin Medical Inc., Plymouth, Minnesota,
USA) and rating of perceived exertion (RPE; Borg, 1970), were recorded during the final 10
seconds of each exercise bout. Blood lactate was determined (Lactate Plus, Nova Biomedical,
MA, USA) from venous blood collected immediately after each submaximal intensity.
Dietary Intervention

Subjects consumed either a NO3- rich (NR) (~12.8 mmol/day) or NO3- depleted (PL)
commercially available beverage (Beet It, James White Drinks Ltd, Ipswich, UK) using a
double-blind, placebo-controlled, cross-over design. During the dietary washout, subjects were
asked to avoid foods high in nitrate content or supplements containing nitrate/nitric oxide/Larginine (Hord et al., 2009). Subjects followed an otherwise normal diet; self-recorded prior to
T2 and then repeated prior to T3.
Venous Blood Sampling

Prior to the maximal exertion test (T1), ~10 mL of venous blood was drawn via
venipuncture into a tube containing ethylenediaminetetraacetic acid (EDTA) for later analysis of
baseline plasma nitrite (NO2-) concentration. Upon arrival at the lab for T2 and T3, an
intravenous catheter (Venflon IV cannula; Becton-Dickinson, Franklin Lakes, New Jersey, USA)
was placed in a prominent forearm vein. The catheter was removed following the post-70%
̇ O2max blood draw. Blood samples (~10 ml) were drawn before exercise and following each
intensity (25, 40, 50, and 60% of ̇ O2max) for analysis of NO2- during both T2 and T3.
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Biochemical Measurements

All tubes were inverted approximately ten times and then centrifuged at 4,000 rpm at
4°C for 6 minutes. Plasma samples were then stored at -80°C for subsequent analysis. Plasma
nitrite was determined in duplicate using a commercially available microplate-based colorimetric
assay kit (Cayman Chemical, protocol # 780001).

Statistical Analysis
Results are presented as mean ± standard deviations. Data were analyzed using a
repeated-measures analysis of variances (ANOVA) with two factors: time and condition. An
alpha level of 0.05 was set for determination of statistical significance.

Results
Plasma Nitrite following consumption of PL or NR beverage

Approximately 2.5 hours after beverage consumption, plasma nitrite (NO2-) was elevated
following supplementation with NR (1.39±1.21 uM) compared to PL (0.70±0.34 uM; p<0.05,
Figure 2).

Oxygen consumption and respiratory exchange ratio

Following NR supplementation, oxygen consumption, recorded as the final 30-sec
average of each stage, was not different at any intensity while exercising at 3500m (p=0.13)
when compared with PL (Figure 3a). Similarly, respiratory exchange ratio was not different
between treatments at any exercise intensity (p=0.17) (Figure 3b).
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Oxygen Saturation and Blood Lactate

During the 70% ̇ O2max intensity, all participants (in both treatments) were above the
lactate threshold. Exercising at 3500m initiated a decline in SaO2 for both conditions. SaO2 was
not different at any intensity when comparing NR and PL (p=0.15) (Figure 4a). However, the
SaO2 of the NR group began to level off at 50% ̇ O2max and remained greater than PL during the
60 and 70% ̇ O2max intensities. During exercise, lactate was lower following NR administration
compared to PL at the 40 and 60% ̇ O2max workloads (p<0.05) (Figure 4b).

Heart rate and rating of perceived exertion

HR was not different between treatments at any exercise intensity (p=0.67) (Figure 5a).
Similarly, rating of perceived exertion was not different in response to NR supplementation
compared with PL at any intensity (p=0.84) (Figure 5a).

Discussion
Acclimatization at 3500m results in a number of physiologic changes including increased
serum and plasma nitrate and nitrite levels (Levett et al., 2011). Increased plasma nitrate
following supplementation has been shown to increase performance in recreationally trained
individuals at sea level; however, the findings at altitude are less conclusive. We hypothesized
exploitation of the nitrate-nitrite-nitric oxide pathway during hypoxia would result in reduced
oxygen cost, which may translate to improved performance. Our study examined oxygen cost at
various intensities (% ̇ O2max) in an effort to determine when dietary nitrate consumption may be
most advantageous during exercise at altitude (3500m).
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Following a similar protocol to that of Larsen (Larsen et al., 2007), the current study
implemented 5-minute bouts of exercise at increasing intensities, each followed by four minutes
of rest. Larsen and colleagues, however, utilized successive 5-minute bouts without rest between
each intensity. The current study administered NR or PL 2.5 hours prior to exercise while
subjects ( ̇ O2max 55 ± 3.7 ml/kg/min) in Larsen’s study consumed sodium nitrate (0.1 mmol/kg)
over two separate 3-day periods (NR and PL). While hypoxia was not incorporated into Larsen’s
study design, they found that nitrate supplementation reduced normobaric oxygen cost during the
lowest 4 workloads (45, 60, 70 and 80% of ̇ O2max). While our results differed in that we found
no change in submaximal ̇ O2 comparing NR to PL, our results were similar in that we found no
difference in exercise HR. Previously, an acute dose of nitrate ~2.5 hours prior to exercise at sea
level has been shown to reduce oxygen cost during moderate intensity exercise (Lansley,
Winyard, Bailey, et al., 2011; Larsen et al., 2010; Vanhatalo et al., 2010; Wylie et al., 2013).
Acute dietary nitrate loading 3 hours prior to exercise has shown increases in plasma nitrite
similar to loading protocols between 3 and 6 days (Bescós et al., 2011; Webb et al., 2008).
Other research has also used similar exercise methodology to that used in the present
study. Under normobaric conditions, Bescós (Bescós et al., 2011) administered an acute dose of
NR 3 hours prior, similar to our administration of NR 2.5 hours prior to exercise. Our subjects
( ̇ O2max 61.01 ± 7.37 ml/kg/min) completed successive 5-minute exercise bouts (40, 50, 60 and
70% of ̇ O2max) separated by 4 minutes of passive recovery; while Bescós’ subjects ( ̇ O2max
65.01 ± 6.2 ml/kg/min) engaged in 6 minutes of exercise (2.0, 2.5, 3.0, and 3.5 watts/kg of body
mass), interspersed with 3 minutes of passive recovery. Our results were similar in that neither
study found a difference in submaximal oxygen cost during low- to moderate-intensity cycling
exercise. Our data also are consistent with their hypothesis that the physiological response to
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cardiorespiratory training, including: increased mitochondrial volume, enzyme activity and
aerobic capacity (Hopker et al., 2009; Tonkonogi & Sahlin, 2002), may reduce the efficacy of
acute nitrate supplementation when compared to lesser or moderately trained subjects (Hoon,
Johnson, Chapman, & Burke, 2013).
Dietary nitrate supplementation prior to exercise in normobaric hypoxia exercise has
been explored with mixed results. A single dose of nitrate consumed 3 hours prior to normobaric
hypoxic exercise (15% O2; equivalent to 2500m) was found to lower ̇ O2 during minute 12 and
15 of a 15-minute exercise bout conducted at 60% of Wattmax (determined at altitude), with no
difference in SaO2 (Muggeridge et al., 2014). Time-trial performance (16.1km) during hypoxic
exposure was significantly improved following nitrate supplementation compared to placebo
(p<0.05). ̇ O2peak of subjects was measured at simulated altitude (51.9 ± 5.8 ml/kg/min)
(Muggeridge et al., 2014). Beyond ~500m, ̇ O2max declines 7-9% for every 1000m increase in
elevation up to 6300m (Robergs, Quintana, Parker, & Frankel, 1998). The current study
measured ̇ O2max under normobaric conditions (1600m). If the ̇ O2max of the present study was
equated to 2500m, the estimated mean ̇ O2max (~56.74 ml/kg/min) would be greater than those
reported for the Muggeridge study. Perhaps the reduction in O2 cost found by Muggeridge can be
partially attributed to the lower training status ( ̇ O2max) of their participants. It is also possible
that the shorter submaximal bout duration of the present study (5-minute bouts) was not long
enough to initiate mechanistic benefit from the conversion of NO3- to NO2- to NO. Separately,
Vanhatalo used normobaric hypoxia of 14.5% O2 (~3000m), and found that, following NR
consumption, high-intensity (48 ± 4 watt) knee extensor time to exhaustion was restored to
values similar to those found during normoxia (Vanhatalo et al., 2011). The duration of hypoxic
exercise for the placebo (393±169 s) was compared to the nitrate group (477±200 s; p<0.05).
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Neither ̇ O2max nor ̇ O2peak values of the subjects were reported for this study, which makes it
difficult to directly compare our results to theirs. Two distinct differences were also present; our
study employed hypobaric hypoxia and was conducted at a greater simulated elevation. Still
other research using 11% inspired O2, corresponding to ~5000m, determined nitrate
supplementation reduced oxygen consumption during a 20-minute exercise bout at a workload
corresponding to 45% ̇ O2max (Masschelein et al., 2012). Masschelein found subjects (61.7 ± 2.1
ml/kg/min) had higher SaO2 and lower lactate following nitrate supplementation (0.07 mmol
nitrate/kg body wt/day for 6 days prior to exercise) compared to the placebo while exercising at
45% ̇ O2max. Their findings for lactate are similar to ours at intensities below 60% ̇ O2max
(3500m), and while our SaO2 data was not statistically different between conditions, we did
determine SaO2 was greater in the highest two workloads (60 and 70% ̇ O2max) following NR
consumption. The simulated elevation of Masschelein’s study was markedly higher and,
therefore, we must use caution when comparing our results to theirs. We suspect exercise greater
than their chosen 45% intensity would be quite difficult to maintain over 20 minutes at 5000m.
While there are distinct differences between normobaric and hypobaric hypoxia (Millet,
Faiss, & Pialoux, 2013; Richard & Koehle, 2012), non-significant changes in ̇ O2 during
submaximal exercise in this study and several others could be attributed to the training status of
the participants. Sea level studies reporting a reduction in submaximal exercise ̇ O2 following
nitrate supplementation consistently reported subjects with mean ̇ O2max values below 60
ml/kg/min. It is therefore plausible that well-trained participants are already receiving the
maximal benefit from physiologic adaptations to endurance training. It is also possible that a
difference in ̇ O2 may have been found if the duration of each intensity in the present study was
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extended; as Muggeridge (Muggeridge et al., 2014) only found a difference during the final
minutes of their 15-minute protocol.
It was hypothesized that NR supplementation would be an effective strategy for reducing
O2 cost during submaximal exercise at altitude, due to the increased potential for conversion of
NO2- to NO (Carriker et al., 2013; Lundberg, Weitzberg, & Gladwin, 2008; Zweier, Wang,
Samouilov, & Kuppusamy, 1995). However, during submaximal exercise at 3500m, NR
supplementation does not appear to provide any benefit when compared to a placebo for welltrained subjects. Future studies should assess the change in oxygen consumption while exploring
different endurance capacities ( ̇ O2max) of subjects, longer duration exercise, and different
elevations. While the cohort used by Masschelein (Masschelein et al., 2012) was similarly
trained compared to ours, their altitude exposure was much higher (~5000m via normobaric
hypoxia). It is therefore possible that, in well-trained participants, the benefit of NR is not
evident until individuals are exposed to much lower barometric pressures. In such a case, a
subject would encounter greater physiologic stress pertaining to gas exchange due to the reduced
partial pressure of oxygen. Therefore, our findings suggest that individuals who are planning to
compete at higher altitudes (or those who seek other physiological advantages) use traditional
altitude acclimatization strategies rather than acute nitrate supplementation (Levine & StrayGundersen, 1997; Wilber, Stray-Gundersen, & Levine, 2007; Wilber, 2011). While nitrate
supplementation may provide benefit during sea level exercise, our research does not support its
efficacy at altitude (3500m). Prior to deriving definitive conclusions regarding dietary nitrate’s
ergogenic potential above sea level, more research is needed.
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Figure Legends
FIGURE 1—A) Schematic timeline: Trial 1 (1600m) and Trial 2+3 (3500m). B) Trial 1 protocol
beginning with ̇ O2max test followed by familiarization trials (25, 40, 50, 60, and 70% of ̇ O2max)
C) Trial 2 and 3 submaximal exercise (25, 40, 50, 60, and 70% of ̇ O2max) during hypobaric
hypoxia (3500m).
FIGURE 2—A) Plasma nitrite concentration (uM) following consumption of placebo (white
bars) or nitrate rich (black bars) beverage 2.5 hours prior to exercise. B) Counterbalanced
placebo consumed prior to either Trial 2 or Trial 3. C) Counterbalanced nitrate rich beverage
consumed prior to either trial 2 or trial 3. Data are presented as the mean ± SD (N=10). *p<0.05
compared with placebo.
FIGURE 3—Oxygen consumption (L/min) during submaximal exercise at 40, 50, 60 and 70%
̇ O2max after placebo (white bars) and nitrate rich (black bars) supplementation 2.5 hours prior to
exercise. B) Respiratory exchange ratio during submaximal exercise after placebo (white bars)
and nitrate rich (black bars) supplementation. Data are presented as the mean ± SD (N=10).
FIGURE 4—A) Oxygen saturation (%) during submaximal exercise at 40, 50, 60, and 70%
̇ O2max after placebo (white bars) and nitrate rich (black bars) supplementation 2.5 hours prior to
exercise. B) Lactate (mmol/L) during submaximal exercise after placebo (white bars) and nitrate
rich (black bars) supplementation. Data are presented as the mean ± SD (N=10). *p<0.05
compared with placebo.
FIGURE 5—A) Heart rate (bpm) during submaximal exercise at 40, 50, 60, and 70% ̇ O2max
after placebo (white bars) and nitrate rich (black bars) supplementation 2.5 hours prior to
exercise. B) Rating of perceived exertion (Borg 6-20) during submaximal exercise after placebo
(white bars) and nitrate rich (black bars) supplementation. Data are presented as the mean ± SD
(N=10).
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Chapter 4 Summary, Conclusions, Recommendations
Summary
The review manuscript entitled “The role of the nitrate-nitrite-nitric oxide pathway
during hypoxia,” provides insight into the potential role which dietary nitrate may play in
individuals exposed to hypoxia. Previous research at sea level alludes to the benefits of dietary
nitrate supplementation including reduced submaximal oxygen consumption, improved exercise
time trial performance, increased time to exhaustion and reduced resting blood pressure. The
oxygen independent reduction of nitrate to nitrite to nitric oxide, in the presence of
deoxyhemoglobin and deoxymyoglobin, points to the ergogenic potential of dietary nitrate while
exercising at altitude. The review paper highlights the effect of dietary nitrate on exposure to
high altitude, maximal exercise, as well as cardiovascular pathology. The underlying mechanistic
or molecular signaling responsible for the physiological benefits of dietary nitrate has yet to be
determined. Larsen’s group (Larsen et al., 2011) previously pointed toward an improvement in
mitochondrial efficiency resulting in improved oxidative phosphorylation efficiency (i.e. the
amount of oxygen consumed per ATP produced; P/O ratio). The limited research surrounding
dietary nitrate and altitude exposure or hypoxia leaves room for many future areas of
investigation.
The research manuscript entitled “Effect of acute dietary nitrate consumption on
submaximal oxygen consumption at altitude” seeks to fill the knowledge gap surrounding the
ergogenic potential of dietary nitrate at altitudes above sea level. This research provides
evidence that dietary nitrate may not possess the same benefits at altitude as previously identified
during exercise at sea level. While exercise and dosing protocols used during our study were
similar to those previously performed, we failed to identify benefits of nitrate consumption in
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variables such as oxygen consumption, oxygen saturation, heart rate, rating of perceived exertion
and exercise blood pressure, which were not different between the placebo and nitrate rich trials.
Therefore, dietary nitrate consumption may not be a viable means of performance enhancement
during exercise at altitude in well-trained subjects.
This study also explored the changes in oxidative stress associated with exercise
following dietary nitrate consumption. Our data showed a significant increase in both catalase
and 8-isoprostane following exercise at 3500m in both the placebo and nitrate rich groups
(Figure 1 and 2). However, there was no difference between groups (placebo vs nitrate rich) for
either of these markers of oxidative stress. Given the acute altitude exposure, the impact which
dietary nitrate has on oxidative stress over prolonged exposure is unknown. Future research
should explore the changes in oxidative stress in individuals residing at high altitude compared to
lowlanders acutely exposed to high altitude. In addition, dietary nitrate may also affect different
populations to various extents. Therefore, future studies should recruit samples of differing
training status, gender, and health (high blood pressure, peripheral arterial disease, etc.).

Conclusions
The principle finding of this research was that an acute dose of dietary nitrate, consumed
2.5 hours prior to exercise at 3500m, does not reduce oxygen consumption at exercise intensities
ranging from 40 to 70% ̇ O2max for well-trained subjects. While other research conducted at sea
level has toted dietary nitrate as ergogenic in nature, the same conclusions are far from
conclusive for dietary nitrate consumed prior to exercise at higher altitudes.
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Recommendations
As previously mentioned, future research should examine different samples including
trained vs untrained, male vs female, and healthy vs unhealthy (high blood pressure or peripheral
artery disease etc.). The duration of exercise should be examined as shorter duration exercise
bouts may not provoke pronounced differences in measured variables. Exercise durations of 1520 minutes appear to be suitable for determining an effect of acute dietary nitrate consumption.
In addition, the altitude examined for this research was 3500m, while other research has explored
the exercise response following dietary nitrate at 2500m, 3000m and 5000m. Further exploration
of these and other elevations is necessary to determine the efficacy of nitrate supplementation,
particularly for sojourners to higher altitudes. In addition, much of the previous research has
used acute (2.5 hour prior) to short term (up to 15 days) nitrate supplementation. The benefit of
dietary nitrate beyond 15 days is unknown. Therefore, prolonged or chronic supplementation
should be examined to determine whether dietary nitrate maintains any benefits seen during the
early stages of supplementation. The literature surrounding dietary nitrate has gained profound
interest in the last 5 years and as a result, this new topic has many additional avenues to explore.
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Figure Legends
FIGURE 1—Catalase activity (nmol/min/ml) immediately following all submaximal exercise
bouts after placebo (white bars) and nitrate rich (black bars) supplementation 2.5 hours prior to
exercise. Data are presented as the mean ± SD (n=9).
FIGURE 2—Isoprostane activity (pg/ml) 60 minutes after completing all submaximal exercise
bouts after placebo (white bars) and nitrate rich (black bars) supplementation 2.5 hours prior to
exercise. Data are presented as the mean ± SD (n=9).
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Appendix A. HIPAA
UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER
HIPAA1 AUTHORIZATION TO USE AND DISCLOSE
PROTECTED HEALTH INFORMATION FOR RESEARCH PURPOSES
Title of Study: Effect of acute dietary nitrate consumption on submaximal oxygen
consumption and oxidative stress in hypoxia

Principal Investigator:
UNMHSC Department:
Mailing Address:
Co-Investigator:

Ann Gibson, Ph.D.
Heath, Exercise, and Sports Sciences
MSC 04-2610, Johnson Center, University of New Mexico,
Albuquerque, NM 87131
Colin Carriker, M.S.

Sponsor: N/A
1. What is the purpose of this form? You have been asked to take part in a research study.
The consent form for this study describes your participation, and that information still
applies. This extra form is required by the federal Health Insurance Portability and
Accountability Act (HIPAA).
2. What if I don’t want my personal health information (PHI) to be used in this research
study? You do not have to give this permission. Your decision not to sign this form will not
change your ability to get health care outside of this research study. However, if you do not
sign, then you will not be allowed to participate in the study.
3. What PHI am I allowing to be used for this research? The information that may be used
includes:
4. a.) VO2max- maximal aerobic capacity
b.) Height, weight, and resting blood pressure
c.) Oxygen consumption during five (5) different intensities of exercise on a treadmill.
5. Where will researchers go to find my PHI? We will ask you to fill out a questionnaire
about your health.
6. Who will be allowed to use my information for this research and why? The
researchers named above and their staff will be allowed to see and use your health
information for this research study. It may be used to check on your progress during the
study, or analyze it along with information from other study participants. Sometimes
research information is shared with collaborators or other institutions. Your records may
also be reviewed by representatives of the research sponsor or funding agency, the Food
and Drug Administration (FDA) to check for quality, safety or effectiveness, or the Human
Research Review Committee (HRRC) for the purposes of oversight and subject safety and
compliance with human research regulations.
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HIPAA is the Health Insurance Portability and Accountability Act of 1996, a federal law related to privacy
of health information.
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7. Will my information be used in any other way? Your information used under this
permission may be subject to re-disclosure outside of the research study and be no longer
protected under certain circumstances such as required reporting of abuse or neglect,
required reporting for law enforcement purposes, and for health oversight activities and
public health purposes.
8. What if I change my mind after I give this permission? You can change your mind and
withdraw this permission at any time by sending a written notice to the Principal Investigator
at the mailing address listed at the top of this form to inform the researcher of your decision.
If you withdraw this permission, the researcher may only use and share your information that
has already been collected for this study. No additional health information about you will be
collected by or given to the researcher for the purposes of this study.
9. What are the privacy protections for my PHI used in this research study? HIPAA
regulations apply to personal health information in the records of health care providers and
other groups that share such information. There are some differences in how these
regulations apply to research, as opposed to regular health care. One difference is that you
may not be able to look at your own records that relate to this research study. These
records may include your medical record, which you may not be able to look at until the
study is over. The HIPAA privacy protections may no longer apply once your PHI has been
shared with others who may be involved in this research.
10. How long does this permission allow my PHI to be used? If you decide to be in this
research study, your permission to access and use your health information in this study may
not expire, unless you revoke or cancel it. Otherwise, we will use your information as long
as it is needed for the duration of the study.

I am the research participant. By signing this form, I am giving permission for my personal
health information to be used in research as described above. I will be given a copy of this
authorization form after I have signed it.
_________________________________
Name of Research Subject

_____________________________
Signature of Subject

____________
Date

_________________________________
Name of Person Obtaining Authorization

_____________________________
Signature

____________
Date
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Appendix B. Informed consent
The University of New Mexico Health Sciences Center
Consent to Participate in Research
Effect of acute dietary nitrate consumption on submaximal oxygen consumption and oxidative
stress in hypoxia
Introduction
You are being asked to participate in a research study conducted by Ann Gibson, Ph.D., the
Principal Investigator, Colin Carriker, M.S., and their associates from the Department of Health,
Exercise, and Sports Sciences. This research is studying the effect of a commercially available
inorganic nitrate beverage on oxygen consumption during sub-maximal exercise.
Previous research has studied the effect of nitrate supplementation during several exercise
intensities at or near sea level elevations. More research is needed to determine if there are
benefits of nitrate supplementation for submaximal exercise performed at high altitude (~11,500
feet). At high altitudes, it is more difficult to get oxygen to the muscles; that can make the same
exercise effort seem harder than it was at a lower elevation. Based on results from research
performed at lower elevations, we believe the nitrate supplement will improve the body’s ability
to deliver oxygen during sub-maximal exercise at high altitude. If we are correct, altitude
performance will improve and there will be fewer markers of oxidative stress (by-products made
as the body makes the energy needed to fuel sub-maximal exercise). Therefore, the purpose of
this study is to examine how the inorganic nitrate supplement affects oxygen consumption and
by-product formation during sub-maximal cycling exercise at a simulated altitude of ~11,500 ft.
This research may add new knowledge about high altitude exercise performance following
supplementation with this nitrate-rich beverage.
You are being asked to participate in this study because you are a trained male cyclist who is free
from any heart, lung, or metabolic diseases. Approximately 30 people will take part in this study
at the University of New Mexico.
This form will explain the research study, and will also explain the possible risks as well as the
possible benefits to you. If you have any questions, please ask one of the study investigators.
What will happen if I decide to participate?
If you agree to participate, the following things will happen:
Overview
1. You will be asked to come to the Exercise Physiology Lab in Johnson Center on the
University of New Mexico main campus three times in approximately 2 weeks.
2. As shown in Figure 1, the first visit (T1), is when all the paperwork will be completed
and baseline information gathered. You will be given the beverage you are to drink
before the next visit. You will be given either the nitrate-rich beverage (Beet It, James
White, Drinks Co.) or a placebo (containing little or no nitrate) beverage. We will
schedule your next visit, give you instructions about how and when to consume your
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assigned beverage, and instruct you on keeping a food log. You will also be given a list
of foods to avoid. Details about the T1 procedures are outlined below (First Visit
section).
3. Figure 1 also shows that the second visit (T2) follows a 4-day period during which you
will consume a low nitrate diet (avoiding the foods on the list we give you). Two hours
before you come to the Exercise Physiology Lab for your scheduled appointment, you
will drink your designated beverage according to the instructions given to you. We will
walk together to the altitude chamber (near Carlisle Gym on the UNM main campus) and
start the preparations for the day’s testing. At the end of T2, we will schedule the third
visit, give you the other beverage, and remind you of the importance to continue avoiding
certain foods and following your food log as closely as possible.
4. The third visit (T3) also follows a 4-day period during which you will consume a low
nitrate diet (avoiding the foods on the list we give you). Two hours before you come to
the Exercise Physiology Lab for your scheduled appointment, you will drink the
designated beverage according to the instructions given to you. We will walk together to
the altitude chamber and start the preparations for the day’s testing.

Figure 1: Proposed Timeline (Start to Finish)

First Visit
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1. During your first visit, you will sign this consent form, HIPAA form and fill out a health
history questionnaire.
2. We will review your medical history form and determine if you qualify to participate, we
will also take your resting blood pressure.
3. You will be directed to the bathroom so you can void your bladder and bowels.
4. Following this, you will put on the heart rate monitor we issued to you and then change
into your exercise attire.
5. After we take your height and weight, we will take a blood sample from one of your
forearm veins.
6. You will then perform a maximal exertion cycling test; this test will last approximately 812 minutes. The test will begin with a warm-up. After that, the workload will be adjusted
so that the pedaling becomes progressively harder. This increase in workload will
continue until you can go no more. Then the workload will be reduced so that you can
cool down for a while.
7. Throughout the maximal exertion cycling test, you will have a breathing mouthpiece in
your mouth and a nose clip over your nose so that we can measure your maximal aerobic
capacity (also known as maximal oxygen consumption or VO2max). There may be some
discomfort associated with the mouthpiece or the nose clip.
8. When the cycling test and cool down are finished, you will rest in a seated position for
approximately 15 minutes. You will then perform five sub-maximal cycling bouts at
different workloads. Each of these bouts will be separated from the next by four minutes
of easy cycling (Recovery). Using these five sub-maximal cycling bouts, we will
determine the workloads for your T2 and T3 sessions.
Second and Third Visit
1. Your second (T2) and third (T3) appointments will start much like T1 did.
2. We will then walk together to the altitude chamber and measure your resting blood
pressure after you have been sitting inside the chamber for ~10 minutes.
3. Afterwards, we will close the altitude chamber door and begin our “ascent” to ~11,500
feet. This will be done by changing the pressure within the chamber (this “ascent” will
take approximately 7-10 minutes). Similar to airplane travel, your ears may ‘pop’ as the
pressure changes. This should not be painful, but may cause some temporary discomfort
until we stabilize the pressure at the simulated altitude of 11,500 feet.
4. While we are “traveling” to our targeted altitude, we will place an indwelling catheter
into one of your forearm veins. This may cause some temporary pain or discomfort after
the initial needle stick. This technique will allow for a small, flexible tube (catheter) to
stay in place and be used for drawing blood. That way we will not need to stick you every
time we need a blood sample. We anticipate that the catheter placement will only take
one needle stick. Should we need to reposition the catheter or make other necessary
adjustments including individual venipuncture (single needle stick), this may require an
additional needle stick(s) throughout the duration of the visit.
5. You will be fitted with a breathing mouthpiece and nose clip just like in T1.
6. You will then cycle for 5-minute bouts. These 5-minute cycling bouts (25, 40, 50, 60 and
70% of your VO2max) are the same as those determined in T1. The 5-minute bouts will be
separated by 4-minute intervals of easy pedaling (Recovery). During the 4-minute
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periods, a blood sample will be taken through the catheter. The catheter will then be
flushed with a standard saline solution to decrease the likelihood a clot will form in it.
7. After the final exercise bout and blood draw, the catheter, mouthpiece, and nose clip will
be removed. We will “descend” to Albuquerque’s elevation and walk back to Johnson
Center.
8. You will have your blood drawn at 30 minutes, 1 hour and 2 hours following the removal
of the catheter. Each of these blood draws will require an additional needle stick
9. During this 2-hour period, you will be free to walk around inside the Exercise Physiology
Lab, but we ask that you avoid additional physical activity. You may wish to bring a
book/computer to occupy your time. We will provide a desk and couch for your
convenience.
10. After the final 2 hour blood draw, your testing session is finished.
11. There may be discomfort during exercise of increasing workloads. Should you need to
stop at any time during the testing process, just let us know and slow down your pedaling.
How long will I be in this study?
Participation in this study will take a total of approximately 8-10 hours over a period of 2 weeks.
Summary of anticipated time:
Visit 1: ~1.5 hours
Visit 2: ~3 hours
Visit 3: ~3 hours
Given the nature of this study, the visits are scheduled at particular intervals; if you anticipate a
scheduling conflict, please let us know immediately so we can best accommodate the conflict.
What are the risks or side effects of being in this study?
Exercise Risks



Possible side effects of maximal exertion exercise include nausea, lightheadedness,
muscle cramps, or dizziness after completion of the exercise.
In people with heart disease, exercise testing to the point of fatigue has a very low risk of
sudden death (1 in 10,000) and complications of the heart (4 in 10,000). Because you are
a trained cyclist accustomed to exercise, the risk is expected to be much less.

There are additional possible risks of physical stress, emotional distress, inconvenience and loss
of privacy and confidentiality (see below) associated with participating in a research study.
Although you may already be accustomed to the cycling intensities used in this study, you may
not be accustomed to the change in altitude. While exercising at ~11,500 feet of elevation, your
maximal intensity exercise capacity (what you could normally perform at the Albuquerque, NM
elevation), may be reduced. Therefore, it may feel more difficult while exercising at a given
workload. Should you need to stop exercising at any time, you may.
While exercising, we will be measuring the amount of oxygen your body is using; you will,
therefore, exercise while breathing through a special mouthpiece that is connected to a flexible
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hose integrated into the computer. There may be some discomfort while exercising with the
mouthpiece in place as your nostrils will be “pinched” shut so that you will be breathing only
through your mouth. It is unlikely that this setup will cause any pain; although, it may be
uncomfortable.
Regarding possible side effects due to the beverages, Beet It, James White, Drinks Co. reports
“The most obvious is that Beet It shots may turn urine pink. There is some anecdotal evidence
that consuming large quantities of beet juice can cause upset stomachs.”
Venous Blood Draw




There may be some pain associated with the needle stick. Some people will experience
only a prick or stinging sensation while others feel a moderate level of momentary pain.
Some people (less than 1 in 10,000) may faint or feel light headed during venous
catheterization. Bruising at the site of the needle stick is possible as is localized infection.
We anticipate that catheterization will require only one needle stick; after that the tubing
remains in place during the exercise testing (while you are completing the cycling trials
on the bike). This allows for easy access during each additional blood draw. While every
effort will be made to keep the blood flowing through the catheter so we can get the
samples we need, there is a possibility a clot will form in it. That would require that we
place another catheter or use single needle sticks to get the blood samples). To reduce the
likelihood of infection, an experienced technician will wear gloves and use an alcohol
swab to sterilize the area where the catheter will be placed or where needle sticks will be
made. To reduce the likelihood of bruising, we will apply pressure at the site once the
needle or catheter has been removed.
After the final exercise bout and blood draw, the catheter will be removed. After the
exercise period this is considered the Recovery Period (Figure 1). You will have your
blood drawn at 30 minutes, 1 hour and 2 hours following the removal of the catheter.
Each of these blood draws will require an additional needle stick

It should also be noted, there may be unforeseen risks to participating in this study. For more
information about risks and side effects, ask the investigator.
How do I know if I am eligible to participate in this study?
You must be a male between the ages of 18 to 45 yrs. Participants must also:
1) Indicate that you performed at least 150 minutes of aerobic activities (predominantly cyclingbased activities) per week for each of the past 8 weeks.
2) Your maximal oxygen consumption from T1 must be higher than that of 69% of the men in
your age group (reference values provided by the American College of Sports Medicine).
What are the benefits to being in this study?
This research may provide insight into the possible benefits of this nitrate-rich supplement for
individuals exercising at sub-maximal intensities at high altitude Elevations.
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While there is no guarantee that you will have a direct benefit as a result of your participation in
the study, all participants will be given the results of their VO2max test upon completion of T3.
Upon request, you will be informed of your performance outcomes for your individual
treatment/trials. As a result, this may be of potential benefit to you.
What other choices do I have if I do not want to be in this study?
Your participation is voluntary, and if you decide to not be in the study then you will not be
contacted again.
How will my information be kept confidential?
We will take measures to protect the security of all your personal information, but we cannot
guarantee confidentiality of all study data.
Information contained in your study records is used by study staff. The University of New
Mexico Health Sciences Center Human Research Review Committee (HRRC) oversees human
subject research and may be permitted to access your records. There may be times when we are
required by law to share your information. However, your name will not be used in any
published reports about this study.
Your information will be stored in a locked file cabinet. In addition, you will be given a study
number that will be used for data collection and analysis. Your information will not be associated
with your study number after the completion of data analysis.
What are the costs of taking part in this study?
The primary cost for participating in this study is your time. If you park on the University
campus, you will be responsible for all parking fees. All nitrate and placebo beverages will be
provided at no cost.
Will I, as a research participant, receive monetary compensation for my time?
No, you will not be compensated for your participation in this study.
What will happen if I am injured or become sick because I took part in this study?
You are responsible for all medical and transport expenses associated with any adverse event,
illness, or accident occurring as a result of your participation in this study.
No commitment is made by the University of New Mexico Health Sciences Center (UNMHSC)
to provide free medical care or money for injuries to participants in this study.
In the event that you have an injury or illness resulting from your participation in this study,
UNMHSC will provide emergency treatment; however, reimbursement for all related costs of
care will be sought from your insurance company, managed care plan, or other benefits program.
If you do not have insurance, you may be responsible for these costs. You will also be
responsible for any associated co-payments or deductibles required by your insurance.
It is important for you to tell the Principal Investigator immediately if you have been injured or
become sick because of taking part in this study. If you have any questions about these issues, or
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believe that you have been treated carelessly in the study, please contact the Human Research
Review Committee (HRRC) at the University of New Mexico Health Sciences Center,
Albuquerque, New Mexico 87131, (505) 272-1129 for more information.
How will I know if you learn something new that may change my mind about participating?
You will be informed of any significant new findings that become available during the course of
the study. Such findings may be related to changes in the risks or benefits associated with this
study or new alternatives to participation that might change your mind about participating.
Can I stop being in the study once I begin?
Your participation in this study is completely voluntary. You have the right to choose not to
participate or to withdraw your participation at any point in this study without affecting your
standing in the community or other services to which you are entitled.
Whom can I call with questions or complaints about this study?
If you have any questions, concerns or complaints at any time about the research study, Ann
Gibson, Ph.D. or her research project associates will be glad to answer them if you call (505)277-2658.
If you need to contact someone after business hours or on weekends, please email
Carriker@unm.edu for communication with Colin Carriker.
If you would like to speak with someone other than the research team, you may call the
UNMHSC HRRC at (505) 272-1129.
Whom can I call with questions about my rights as a research participant?
If you have questions regarding your rights as a research participant, you may call the UNMHSC
HRRC at (505) 272-1129. The HRRC is a group of people from UNM and the community who
provide independent oversight of safety and ethical issues related to research involving human
participants. For more information, you may also access the HRRC website at
http://hsc.unm.edu/som/research/hrrc/.

Consent to Participate
By signing this consent form, you are not giving up any legal rights. Your signature means that you understand
the study plan, have been able to ask questions about the information given to you in this form, and you agree
to join the study.
We will give you a copy of this consent form to keep for your personal records.

Participant Printed Name

Signature

Date

Principal Investigator

Signature

Date

All of the following components are optional, please indicate whether you agree to consent
by checking the yes or no box. In addition, please print and sign your name, only if you
selected the YES checkbox.
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Consent to retain de-identified blood samples for academic purposes
Yes

No

By signing below, you are not giving up any legal rights. Your signature indicates you are willing to allow
your blood samples to be de-identified and kept beyond the study period. These samples would be used for
academic purposes such as future student practice of biochemical assay techniques. If consent is not provided
below, your blood samples will be de-identified and destroyed according to OSHA regulations at the end
of the study period.

Participant Printed Name

Signature

Date

Principal Investigator

Signature

Date

Consent to contact participant for alternative/continuation studies
Yes

No

By signing below, you are not giving up any legal rights. Your signature indicates you would like to be
contacted for any follow-up studies similar to the present study. If consent is not provided below, you will
not be contacted for anything outside the purposes of the present study.

Participant Printed Name

Signature

Date

Preferred email address:___________________________________________________________

Principal Investigator

Signature

Date

FOR RESEARCH TEAM ONLY
I have explained the research to the participant and answered all of his questions. I believe that he
understands the information described in this consent form and freely consents to participate.
_________________________________________________
Name of Investigator/ Research Team Member (type or print)
_________________________________________________
Signature of Investigator/ Research Team Member)

___________________
Date
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Appendix C. Participant contact information form
Participant Contact information
Subject Name_____________________________

Date___/___/___

Phone #: home________________________ cell_______________
Date of Birth ___/___/___ Age____ Gender____ Ethnicity_______
Phone (W)________________
Address
(home)_________________________________zip__________email______________________
Primary health care provider and health
insurance_____________________________________________
(Only for information/emergency contact)
Person to contact in case of emergency: name______________________phone #____________

Date
Contacted
_________

Reason

_________

___________________________________________________________

_________

___________________________________________________________

_________

___________________________________________________________

_________

___________________________________________________________

_________

___________________________________________________________

___________________________________________________________
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Appendix D. Flyer

University of New Mexico Research Study
In Albuquerque, NM
HRPO study #13-583

Version 12/05/2013

Effect of inorganic nitrate (Beet It; James White Drinks Ltd., Ipswich, United Kingdom, U.K.)
supplementation on oxygen consumption during submaximal exercise in trained cyclists.

Are you a trained male cyclist?
Do you have a very high aerobic capacity for your age and gender
We’d love to have you participate in our exercise research study!



We are looking for males age 18 to 45 years
Participants cannot have cardiac, peripheral vascular, cerebrovascular disease, chronic obstructive
pulmonary disease, asthma, interstitial lung disease, or cystic fibrosis, diabetes mellitus (type I or
II), thyroid disorders, renal or liver disease.
Participants must meet the following pre-requisites:
1) Achieve a VO2max value tested on a cycle ergometer above the 70th percentile for your age and
sex
2) Primarily reside at ~1600 m for the previous 6 months and agree to avoid extended-travel
which will incur a change in altitude greater than 500 m.
3) Self-report engaging in cardio based activities >150 minutes/week for a minimum of 8
consecutive weeks preceding enrollment in the study.






You will be asked to exercise on 3 different days over a period of approximately 2 weeks
You will consume a beverage provided at no cost (2 hours prior to Trial 2 and Trial 3)
Trial 1: Complete a maximal aerobic effort stationary cycle test (VO2max).
Trial 2: Complete five (5) different intensity 5-minute cycle exercise bouts separated by a 4-min
break.
 Trial 3: Complete five (5) different intensity 5-minute cycle exercise bouts separated by a 4-min
break.
 At each trial we will draw your blood. There is no cost to participate in this study.
Contact: Colin Carriker at Carriker@unm.edu) for more information about this voluntary
research study: Please email with subject line: UNM Nitrate Research OR call 505.277.2658
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Appendix D. Health History Questionnaire
HEALTH HISTORY QUESTIONNAIRE
Subject Name_____________________________

Date___/___/___

Phone #: home________________________ cell_______________
Date of Birth ___/___/___

Age____ Gender____ Ethnicity_______ Phone (W)_________

Address (home)_________________________________zip__________email______________________
Primary health care provider and health insurance______________________________________
(Only for information/emergency contact)
Person to contact in case of emergency: name______________________phone #____________


MEDICAL HISTORY
Self-reported: Height______ Weight______
A. Are you currently injured?
 Yes
If yes what is the nature of your injury:

 No

B. Have you suffered an injury in the last 6 months?
If yes what was the nature of your injury:

 Yes

 No

C. Have you previously sustained a knee injury or had knee surgery?
If yes, please explain knee history and present condition/limitations:
________________________

 Yes

 No

Have you ever had any of the following cardiovascular problems? Please check all that apply.
Heart attack/Myocardial Infarction____
Chest pain or pressure
____
Arrhythmias/Palpitations
____

Heart surgery
Swollen ankles
Heart murmur

____
____
____

Valve problems
Dizziness
Shortness of breath

_____
_____
_____

Have you ever had any of the following? Please check all that apply.
Hepatitis/HIV
Rheumatic fever
Kidney/liver disease
Diabetes (specify type)
Emphysema

_____
_____
_____
_____
_____

Depression
_____
High blood pressure_____
Obesity
_____
Asthma
_____
Stroke
_____

Cancer (specify type)
Thyroid problems
Total cholesterol >200 mg/dl
HDL cholesterol <35 mg/dl
LDL cholesterol >135 mg/dl
Trygylcerides>150 mg/dl

Do immediate blood relatives (biological parents & siblings only) have any of the conditions listed
above? If yes, list the problem, and family member age at diagnosis.
______________________________________________________________________________
Is your mother living? Y N
Is your father living? Y N

Age at death______
Age at death______

Cause___________________
Cause___________________

Do you currently have any condition not listed that may influence test results? Y

N

Details________________________________________________________________________
Indicate level of your overall health. Excellent ____ Good ____ Fair ____ Poor_____

_____
_____
_____
_____
_____
_____
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Are you taking any medications, vitamins or dietary supplements now?

Y

N

If yes, what are
they?____________________________________________________________________
Do you have allergies to any medications? If yes, what are they? ________________________
Are you allergic to latex?

Y

N

Have you been seen by a health care provider in the past year?

Y

N

If yes, elaborate ________________________________________________________________
Have you had a prior stationary cycle test? Y N.
If yes, when?___________
What were the results?__________________________________________________________________
Have you ever experienced any adverse effects during or after exercise (fainting, vomiting, shock,
palpitations, hyperventilation)? Y N If yes, elaborate.________________________
______________________________________________________________________________


LIFESTYLE FACTORS
Do you now or have you ever used tobacco?
How long?______

Y N

Quantity____/day

If yes: type ________________
Years since quitting______________

How often do you drink the following?
Caffeinated coffee, tea, or soda _______oz/day
_______oz/week Beer _______oz/wk

Hard liquor _______oz/wk

Wine

Indicate your current level of emotional stress. High____ Moderate ____ Low____


PHYSICAL ACTIVITY/EXERCISE
Physical Activity
How many times per week do you exercise 30 minutes/day or more? (CIRCLE ONE)
01

2

3

4

5

6

7

Please explain the type of exercise or activities you regularly participate in.
Cardiovascular_________________________________________________________________
Strength Training_______________________________________________________________
Flexibility/Stretching____________________________________________________________
Do you train in any activity (eg. stationary cycling, road cycling, spin class)?

Y

N

Rate your current cycling ability on a scale from 0 to 5 (CIRCLE ONE)
Poor -- 0

1

2

3

4

5 -- Excellent

In a given week, how often do you engage in Vigorous Exercise (>20 Minute sessions)
_________ times per week
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Appendix E. List of food sources rich in nitrate
List of Food Sources Rich In Nitrates
* Hord, Norman. "Food Sources of Nitrates and Nitrites: The Physiologic Context for Potential
Health Beneﬁts." The American Journal of Clinical Nutrition 90 (2009): 1-10. Print.

During the course of your participation, you are asked to avoid food sources classified as
Middle, High, or Very High in Nitrates. These levels are described in Table 1 with
suggestions of what foods to avoid. These foods high in nitrates are strictly found in
vegetables, and according to Hord et al… (referenced in Table 1) nitrates are low to very
low in fruits and meats, as demonstrated in table 2. Therefore, should avoid foods listed in
Table 1 while you are in this study.
Table 1

Table 2

